Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STYX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIGM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UMAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEATR5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UXS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHORDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY19L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMSY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRD5A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on